Second state in the USA stocks Impavido (miltefosine) for Leishmaniasis and off-label emergency use
South Carolina because the second state after Texas to participate in a non-charge consignment program from Profounda in an effort to...
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO